Sriram Venkataraman - 08 Aug 2022 Form 4 Insider Report for RVL Pharmaceuticals plc

Signature
By: /s/ Sriram Venkataraman
Issuer symbol
N/A
Transactions as of
08 Aug 2022
Net transactions value
+$12,400,000
Form type
4
Filing time
09 Aug 2022, 17:19:26 UTC
Previous filing
09 Aug 2021
Next filing
30 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Purchase $12,400,000 +8,000,000 +51% $1.55 23,730,864 08 Aug 2022 By Avista Capital investment fund F1
holding RVLP Ordinary Shares 1,032,995 08 Aug 2022 By Avista Capital investment fund F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
F2 Represents shares of the Issuer held by Orbit Co-Invest III LLC. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit Co-Invest III LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.